Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The equine epididymis mainly uses type 1 5α-reductase, and both finasteride and dutasteride can inhibit its activity.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

Human hair follicles can process steroid hormones like DHEA.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Gene mutations can cause problems in male genital development.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

New genes and pathways are important for testosterone production and male sexual development.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Sebocytes play a key role in controlling androgen levels in human skin.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

New progesterone-based compounds can block male hormones.